GS-0201

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-0201, covering 2025-03-12 to 2025-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors [Phase 1]